Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPO
401
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $29.2M | 0.03% |
612,163
-68,170
| -10% | -$2.79M |
|
|
SGMO
402
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $28.4M | 0.03% |
1,857,818
-158,395
| -8% | -$2.28M |
|
403
United Natural Foods
UNFI
$2.96B
| $28.4M | 0.03% |
435,681
-814
| -0.2% | -$54.4K |
|
|
KIN
404
DELISTED
Kindred Biosciences, Inc.
KIN
| $28.1M | 0.03% |
1,507,485
+599,295
| +66% | +$10.2M |
|
|
UTX.PRA
405
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
| $26.8M | 0.02% |
411,700
-148,300
| -26% | -$9.77M |
|
|
IRF
406
DELISTED
INTL RECTIFIER CORP
IRF
| $26.6M | 0.02% |
955,092
+30,533
| +3% | +$818K |
|
|
LPNT
407
DELISTED
LifePoint Health, Inc.
LPNT
| $26.5M | 0.02% |
426,950
-6,977
| -2% | -$409K |
|
|
VR
408
DELISTED
Validus Hold Ltd
VR
| $26M | 0.02% |
679,685
-9,839
| -1% | -$366K |
|
409
Kosmos Energy
KOS
$1.48B
| $25.9M | 0.02% |
2,310,438
+7,734
| +0.3% | +$82.7K |
|
410
Guidewire Software
GWRE
$12.4B
| $25.7M | 0.02% |
+631,597
| New | +$25M |
|
|
MDCO
411
DELISTED
Medicines Co
MDCO
| $25.6M | 0.02% |
880,137
-424,599
| -33% | -$11.3M |
|
412
Kinross Gold
KGC
$28.4B
| $24.2M | 0.02% |
5,838,040
+1,990,888
| +52% | +$8.1M |
|
|
RP
413
DELISTED
RealPage, Inc.
RP
| $24.1M | 0.02% |
1,073,699
+2,508
| +0.2% | +$49.4K |
|
|
MWE
414
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $24.1M | 0.02% |
336,009
-339,357
| -50% | -$21.9M |
|
|
BLUE
415
DELISTED
bluebird bio
BLUE
| $23.9M | 0.02% |
47,761
-8,634
| -15% | -$2.77M |
|
|
DYN
416
DELISTED
Dynegy, Inc.
DYN
| $23.8M | 0.02% |
+682,905
| New | +$21.1M |
|
|
CMO
417
DELISTED
Capstead Mortgage Corp.
CMO
| $23.2M | 0.02% |
1,764,853
+105,119
| +6% | +$1.36M |
|
|
CLDT
418
Chatham Lodging
CLDT
$632M
| $22.8M | 0.02% |
1,041,099
-1,016
| -0.1% | -$22K |
|
|
JOY
419
DELISTED
Joy Global Inc
JOY
| $22.3M | 0.02% |
+362,093
| New | +$21.8M |
|
|
SUSS
420
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
| $22.1M | 0.02% |
274,085
-37,600
| -12% | -$2.78M |
|
|
CYT
421
DELISTED
CYTEC INDS INC
CYT
| $22.1M | 0.02% |
418,428
-1,356
| -0.3% | -$67K |
|
|
CHC
422
DELISTED
CHINA HYDROELECTRIC CORP SPONSORED ADR RPSTG 3 ORD SHS
CHC
| $21.6M | 0.02% |
6,303,216
| – | – |
|
|
CIM
423
Chimera Investment
CIM
$1.05B
| $21.5M | 0.02% |
448,959
-466
| -0.1% | -$21.9K |
|
|
GWPH
424
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $21.4M | 0.02% |
199,316
+8,743
| +5% | +$608K |
|
425
Accenture
ACN
$94.7B
| $21.3M | 0.02% |
263,801
-662,854
| -72% | -$53.2M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.